A reduced ability of red blood cells (RBC) to bind the cationic dye alcian blue 8GX (AB) was proposed as an indirect marker of glomerular loss of fixed polyanions in minimal change nephrotic syndrome and glomerulosclerosis.' 2 The importance of this test in other glomerulopathies was not confirmed3 and its analytical validity was questioned,4 the main problem being the incomplete solubilisation of the dye. The latter problem may, however, be overcome by dissolving AB in 100% ethanol.5 Recently, it has been shown that RBCs from workers exposed to cadmium have a reduced ability to bind AB.6 Since bound AB was negatively related to albuminuria, it was interpreted as the mirror of a loss in fixed polyanionic charges at the glomerular level. This view was supported by the parallelism between RBC and glomerular basement membranes from experimentally poisoned rats as to their ability to bind AB. We report here findings that substantially confirm those presented by Bernard et al. 6 They also, however, cast doubt on the pathophysiological meaning of this test.
Materials and methods
In a small series of 10 subjects with heavy past exposure to cadmium and in 24 control subjects we examined the urinary excretion of albumin, retinol binding protein (RBP), and brush border antigens by enzyme linked immunosorbent assays.7-9 The urinary excretion of cadmium was measured by flameless atomic absorption spectroscopy (Perkin-Elmer, model 3030 Zeeman) and was taken as a measure of cadmium body burden. Urinary concentrations were normalised to I g of creatinine.
Results and discussion Albuminuria, urinary RBP, and BBA were signifiAccepted 25 April 1988 cantly higher in those exposed to cadmium compared with control subjects (table). Thus our results confirm the previous observations of Bernard et al suggesting a decreased ability of RBC from workers exposed to cadmium to bind AB, such a difference being clearly shown by visual inspection of the figure. 6 The amount of AB bound to RBC, however, was correlated not only with albuminuria and cadmiumuria (r = -0 73 and -0-62, respectively; p < 0-05) but also with low molecular weight proteinuria, as measured by urinary RBP (r = -072; p = 0 02). No relation was found between AB binding to RBCs and the urinary excretion of brush border antigens. The negative correlations of AB binding to RBCs with urinary RBP (uRBP) and cadmium-which in urine also is mainly bound to the low molecular weight protein metallothionein-suggest that AB binding to RBC may mirror not only glomerular but also tubular dysfunction. Such a hypothesis would not be consistent with the lack of correlation with the urinary excretion of brush border antigens. Nevertheless, the latter reflects microtissue damage, which does not necessarily parallel tubular dysfunction in subjects with past exposure to cadmium. As a result, AB binding to RBCs seems to show cadmium induced abnormalities which are not confined within the vascular compartment or are not simply related to glycosaminoglycan Mean values of Cd-U, albumin, retinol binding protein, and bound alcian blue in workers occupationally exposed to cadmium and in a control group. All valuesfrom the exposed group are significantly higher than in controls (p < 0 01) Exposed In separate experiments we also investigated the effects of reducing agents on the RBC-AB binding assay. In the absence of any appreciable precipitation, they enhanced AB binding in a dose dependent manner. For instance, when RBCs were coincubated with 1 mmol GSH and AB, the binding of the dye increased by 100%. Interestingly, no changes were seen in AB binding when RBCs were preincubated with GSH, suggesting that the enhanced reactivity of AB by reducing agents is due to changes in the dye rather than in membrane charges. In fact, GSH may only reduce the cationic properties of the dye, which could increase its hydrophobic interactions.
The possible target selectivity of AB still remains a tempting hypothesis open to question. In fact, the above experiments lead to the conclusion that the AB actually measures something on RBC membranes, but certainly something other than electronegative charges. It could be used to probe hydrophobic patches on such surfaces, among which phospholipids such as sphingomyelin are good candidates.'0 In summary, AB binding assay may be a good marker of some generalised membrane disorders, which are detectable not only among workers chronically exposed to cadmium but also in other clinical conditions. Such membrane disorders, however, may be represented by changes in the hydrophobic domains of the membrane rather than in its sialic acid residues. 
